MARVELL TECHNOLOGY, INC (MRVL) Spending and interest coverage
- R&D / revenue · 12 months: Value 25.84%; Formula and calculation Research and development expense / revenue. Period ending 2026-08-01..
- Stock-based compensation / revenue · 12 months: Value 8.77%; Formula and calculation Share-based compensation / revenue. Period ending 2026-08-01..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-08-01; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 25.84% | Research and development expense / revenue. Period ending 2026-08-01. $2.44B ÷ $9.45B × 100 ≈ 25.84% |
| Stock-based compensation / revenue · 12 months | 8.77% | Share-based compensation / revenue. Period ending 2026-08-01. $828.90M ÷ $9.45B × 100 ≈ 8.77% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 2.44B USD | Research and Development Expense |
| Revenue | 9.45B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 828.90M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.56B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 | $2.44B | $9.45B | $828.90M | $1.56B | (m) | 25.84% | 8.77% | (m) | (m) |
| 2026-05-02 | $2.22B | $8.72B | $656.30M | $1.39B | (m) | 25.46% | 7.53% | (m) | (m) |
| 2026-01-31 | $2.08B | $8.19B | $590.80M | $1.32B | (m) | 25.32% | 7.21% | (m) | (m) |
| 2025-11-01 | $2.04B | $7.79B | $595.40M | $1.15B | (m) | 26.15% | 7.64% | (m) | (m) |
| 2025-08-02 | $2.01B | $7.23B | $601.70M | $93.10M | (m) | 27.84% | 8.32% | (m) | (m) |
| 2025-05-03 | $1.98B | $6.50B | $603.00M | $-297.40M | (m) | 30.48% | 9.27% | (m) | (m) |
| 2025-02-01 | $1.95B | $5.77B | $597.40M | $-720.30M | (m) | 33.82% | 10.36% | (m) | (m) |
| 2024-11-02 | $1.91B | $5.38B | $605.10M | $-988.80M | (m) | 35.54% | 11.25% | (m) | (m) |
| 2024-08-03 | $1.90B | $5.28B | $605.20M | $-432.30M | (m) | 36.06% | 11.46% | (m) | (m) |
| 2024-05-04 | $1.89B | $5.35B | $603.10M | $-537.60M | $207.80M | 35.38% | 11.28% | -2.59× | Reported |
| 2024-02-03 | $1.90B | $5.51B | $609.80M | $-567.70M | $211.70M | 34.43% | 11.07% | -2.68× | Reported |
| 2023-10-28 | $1.88B | $5.50B | $585.20M | $-511.10M | $208.40M | 34.18% | 10.64% | -2.45× | Reported |
| 2023-07-29 | $1.85B | $5.62B | $572.80M | $-259.00M | $201.00M | 32.87% | 10.20% | -1.29× | Reported |
| 2023-04-29 | $1.82B | $5.79B | $564.50M | $-14.20M | $187.00M | 31.43% | 9.74% | -0.08× | Reported |
| 2023-01-28 | $1.78B | $5.92B | $552.40M | $238.00M | $170.60M | 30.14% | 9.33% | 1.40× | Reported |
| 2022-10-29 | $1.74B | $5.84B | $556.48M | $249.43M | $156.34M | 29.78% | 9.52% | 1.60× | Reported |
| 2022-07-30 | $1.66B | $5.52B | $529.48M | $110.23M | $146.54M | 30.16% | 9.60% | 0.75× | Reported |
| 2022-04-30 | $1.58B | $5.08B | $499.08M | $-195.57M | $140.54M | 31.17% | 9.83% | -1.39× | Reported |
| 2022-01-29 | $1.42B | $4.46B | $460.68M | $-347.67M | $139.34M | 31.92% | 10.32% | -2.50× | Reported |
| 2021-10-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-05-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-30 | $1.07B | $2.97B | $241.54M | $-258.39M | $69.26M | 36.13% | 8.14% | -3.73× | Reported |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-08-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-05-02 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-02-01 | $1.08B | $2.70B | $242.21M | $-243.36M | $85.63M | 40.03% | 8.97% | -2.84× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TEXAS INSTRUMENTS INC (TXN) | United States | $247.134B | 44.82 |
| ANALOG DEVICES INC (ADI) | United States | $185.351B | 43.06 |
| APPLIED MATERIALS INC /DE (AMAT) | United States | $376.264B | 45.97 |
| MONOLITHIC POWER SYSTEMS, INC. (MPWR) | United States | $65.671B | 84.84 |
| Astera Labs, Inc. (ALAB) | United States | $62.547B | 226.73 |
| NXP Semiconductors N.V. (NXPI) | $58.101B | 17.92 | |
| MICROCHIP TECHNOLOGY INC (MCHP) | United States | $40.549B | 103.49 |
| Credo Technology Group Holding Ltd (CRDO) | Cayman Islands | $36.813B | 72.27 |
| ON SEMICONDUCTOR CORP (ON) | United States | $28.502B | 56.37 |
| Qnity Electronics, Inc. (Q) | United States | $25.588B | 54.28 |